FWBI - What's Going On With First Wave BioPharma Stock? | Benzinga
First Wave BioPharma, Inc. (NASDAQ: FWBI) shares are trading higher Wednesday.
What To Know:
First Wave BioPharma then announced on Dec. 27 that it had entered into a non-binding agreement to sell its niclosamide program for the treatment of inflammatory bowel diseases to an undisclosed biopharmaceutical company in order to streamline its clinical pipeline.
The non-binding term ...